Pfizer Inc. funds projects to train Japanese healthcare professionals in advanced, evidence-based strategies for preventing pediatric infectious diseases.
Funder: Pfizer Inc.
Due Dates: September 15, 2026 (Full Proposal submission)
Funding Amounts: Up to 30,000,000 JPY per project (max 2 years; includes direct and indirect costs, with overhead capped at 28%)
Summary: Supports independent medical education projects to develop healthcare professionals in Japan with advanced expertise in pediatric infectious disease prevention and vaccination strategies.
Key Information: Applications must be submitted via a new online system launching mid-August 2026; only organizations are eligible.
This grant opportunity, offered by Pfizer Inc., aims to advance preventive strategies in pediatric infectious diseases in Japan by supporting independent medical education initiatives. The focus is on cultivating healthcare professionals—including physicians, pharmacists, nurses, and others—with advanced expertise in interpreting and applying the latest scientific evidence on epidemiological trends, vaccine effectiveness and safety, and evolving guidelines (including maternal immunization). Projects should enable these professionals to lead and implement evidence-based infectious disease prevention strategies nationwide, ultimately strengthening infection control systems and improving health outcomes for children in Japan.